Exegenesis Bio is a Gene therapy start-up.
Exegenesis is going to develop new medicine based on gene therapy and focuses on China and the global market. The team consists of experienced professionals, including gene therapy drug design, preclinical studies and clinical development.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Feb 2, 2021 | Series B | — | 1 | — | — | Detail |
Oct 21, 2019 | Seed | $10M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Xianfeng Qiyun | — | Series B |
Lenovo Star | — | Seed |